https://www.aigom.it/wp-content/uploads/2026/02/ART24.2.png1059700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-24 07:47:032026-02-24 07:47:03PALBOCICLIB FOR HORMONE-RECEPTOR POSITIVE, HER2-POSITIVE ADVANCED BREAST CANCER.
https://www.aigom.it/wp-content/uploads/2026/02/ART17.2.png1030700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-17 09:13:392026-02-17 09:13:39TRASTUZUMAB DERUXTECAN PLUS PERTUZUMAB FOR HER2-POSITIVE METASTATIC BREAST CANCER
https://www.aigom.it/wp-content/uploads/2026/02/ART10.2-1.png1154700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-10 08:09:292026-02-10 08:14:33IMMUNE CHECKPOINT INHIBITORS FOR MISMATCH REPAIR-DEFICIENT GASTROESOPHAGEAL ADENOCARCINOMA: OUTCOMES AND FEASIBILITY OF NONOPERATIVE MANAGEMENT AT MAYO CLINIC.
https://www.aigom.it/wp-content/uploads/2026/02/ART3.2.png1172700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-02-03 08:31:362026-02-03 08:31:36ADJUVANT EPIRUBICIN PLUS CYCLOPHOSPHAMIDE FOLLOWED BY TAXANES WITH OR WITHOUT CARBOPLATIN IN EARLY-STAGE TRIPLE-NEGATIVE BREAST CANCER (RJBC 1501): A RANDOMIZED PHASE III TRIAL.
https://www.aigom.it/wp-content/uploads/2026/01/ART27.1.png1120700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-01-27 09:05:342026-01-27 09:05:34MANAGEMENT OF CANCER DURING PREGNANCY: ASCO GUIDELINE-2026
https://www.aigom.it/wp-content/uploads/2026/01/ART20.1.png973700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-01-20 08:30:502026-01-20 08:30:50STRUCTURED EXERCISE AFTER ADJUVANT CHEMOTHERAPY FOR COLON CANCER.
https://www.aigom.it/wp-content/uploads/2026/01/ART13.1.png1073760Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-01-13 09:28:182026-01-13 09:28:18PREVALENCE AND ASSOCIATED FACTORS OF CHRONIC PAIN AMONG NURSES: A NATIONAL CROSS-SECTIONAL STUDY.
https://www.aigom.it/wp-content/uploads/2025/12/ART2.12.png1133700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-12-02 08:20:352025-12-01 14:39:05POSTMASTECTOMY RADIATION THERAPY: AN ASTRO/ASCO/SSO CLINICAL PRACTICE GUIDELINE.
https://www.aigom.it/wp-content/uploads/2025/11/ART25.11.png1193743Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-11-25 11:13:322025-11-25 11:13:32CLINICAL CHARACTERIZATION OF FGFR2b EXPRESSION IN PATIENTS WITH ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
